Rifamycins, their compositions and use as antibiotics

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602393P, 435119, 435253, A61K 31395, C07D49108

Patent

active

044118961

ABSTRACT:
New antibiotically active compounds having the basic structure of rifamycin S, namely 3-hydroxyrifamycin S (formula A: X=>C.dbd.O; R.sup.1 =OH; R.sup.2 =H), 3,31-dihydroxy-rifamycin S (formula A: X=>C.dbd.O; R.sup.1 =R.sup.2 =OH) and 1-desoxy-1-oxarifamycin S (formula A: X=--O--; R.sup.1 =R.sup.2 =H) ##STR1## are formed by cultivating, under aerobic conditions, a strain of Nocardia mediterranei which is derived from Streptomyces mediterranei ATCC 13 685 as the parent strain and is characterized by the ability to produce at least one of the mentioned compounds. The recombinant strain Nocardia mediterranei DSM 1415 has proved suitable. The mentioned rifamycin S analogues have analogous antibiotic properties to this but have a wider range of action, especially against gram-negative bacteria.

REFERENCES:
Yang et al. "J. Nat. Cancer Institute", vol. 49, No. 1, Jul. 1972, pp. 7-25 (Note p. 14).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Rifamycins, their compositions and use as antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rifamycins, their compositions and use as antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rifamycins, their compositions and use as antibiotics will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-712551

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.